Updates are available Correction dated 2023-03-16
Click to view Correction: https://doi.org/10.1007/s40273-023-01263-w
-
Authors
Goswami, Hardik
Alsumali, Adnan
Jiang, Yiling
Schindler, Matthias
Duke, Elizabeth R.
Cohen, Joshua
Briggs, Andrew
Puenpatom, Amy
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
- License Information
-
More Information
Article History
Accepted: 19 June 2022
First Online: 2 July 2022
Change Date: 16 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40273-023-01263-w
Declarations
:
: This work was supported by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
: Hardik Goswami, Adnan Alsumali and Amy Puenpatom are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, who may own stock and/or stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Yiling Jiang is an employee of MSD (UK) Ltd, who may own stock and/or stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Matthias Schindler is an employee of MSD (Switzerland) Ltd., who may own stock and/or stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Elizabeth Duke was the site principal investigator for the clinical trial from which these data were drawn and for the ongoing MK4482-013 clinical trial studying molnupiravir for prevention of COVID-19 in household contacts. Her institution, Fred Hutchinson Cancer Research Center, received funding from Merck & Co., Inc. to conduct these studies but the funding was not tied to study outcomes. Joshua Cohen received compensation from Merck & Co., Inc. as a consultant for this work. Andrew Briggs received compensation from Merck & Co., Inc. as a consultant for this work. He has also been contracted by Bayer, Eisai, Janssen, Novartis, Sword Health, Amgen, and Daichii Sankyo and received compensation outside of the submitted work.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: This was a cost-effectiveness study and no ethics approval was required.
: Consent to participate was not required for this study.
: Consent to publish was not required for this study.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
